Remove Disease Remove Imaging Remove MRI
article thumbnail

MRI predicts Parkinson's disease progression

AuntMinnie

MRI illuminates the structural and functional organization of the brain -- thus helping clinicians predict the progression of Parkinson's disease in patients in its early stages, researchers have found. The results were published June 25 in Radiology. "[Our

Disease 105
article thumbnail

Brain Connectivity on MRI Predicts Parkinson’s Disease Progression

Imaging Technology

milla1cf Tue, 06/25/2024 - 19:03 June 25, 2024 — The structural and functional organization of the brain as shown on MRI can predict the progression of brain atrophy in patients with early-stage, mild Parkinson’s disease, according to a study published today in Radiology , a journal of the Radiological Society of North America ( RSNA ).

Disease 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MRI findings predict Parkinson's disease progression

Health Imaging

MR imaging could provide insight into how Parkinson’s disease will progress years before its related symptoms become debilitating.

Disease 116
article thumbnail

AI-Driven Imaging Platform Analyzes MRI Data for Early Detection of Age-Related Diseases

MedImaging MRI

An AI-driven imaging platform for the identification of age-related diseases utilizes sophisticated AI algorithms to examine MRI data and offer.

Disease 97
article thumbnail

Study Assesses Amyloid PET/MRI Combination in Detection of Alzheimer’s Disease

Diagnostic Imaging

Emerging research revealed that a machine learning combination of amyloid beta PET and structural MRI demonstrated an 89 percent AUC in differentiating between older healthy patients and those with Alzheimer’s disease.

Disease 86
article thumbnail

DMI feasible in Alzheimer’s disease patients

AuntMinnie

Deuterium metabolic imaging (DMI) can reveal impaired brain glucose metabolism in patients with Alzheimer’s disease, according to a study published July 16 in Radiology. However, the use of PET remains limited by its higher cost and lower availability than MRI, according to the authors.

Disease 103
article thumbnail

New PET/MRI probe promises early discovery of covert diseases

Medical Xpress: Radiology

A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can be used in both magnetic resonance imaging (MRI) and positron emission tomography (PET).